The legislation proposed the formation of a Medicare Drug Shortage Mitigation Program tasked with improving contracting and purchasing in the pharmaceutical supply chain by 2027, according to The Hill.
Other provisions would require Medicare suppliers to create stricter standards to bolster the reliability and transparency of generic drug purchasing in order to receive Medicare payment incentives, the publication said.
Another provision would require contracts for a minimum of three years with manufacturers, purchase volume commitments and transparency about manufacturer quality issues, The Hill reported.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.